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Background: The aim of this study is to determine the validity and reliability of the Cantonese Chinese version of
the Kidney Disease Quality of Life-36 (KDQOL-36™) questionnaire. The scale has been translated into Cantonese
Chinese, but has not been tested among the Cantonese-speaking populations.
Methods: A total of 110 dialysis patients and 122 renal transplant patients were recruited. The data for the KDQOL-
36™ were extracted from the KDQOL-Short Form. The criterion validity and scale equivalence were examined using
the KDQOL-Short Form scores as the gold standard. The Hospital Anxiety and Depression scale was used to identify
the correlations between depression, anxiety, and quality of life to establish the convergent validity. Discriminant
validity was examined using the transplant patients to compare the quality of life of dialysis patients. The Cronbach’s
alpha coefficient and test-retest were used for estimating reliability.
Results: There were very strong positive correlations for the physical and mental component summary between the
KDQOL-36™ and KDQOL-Short Form. Despite the strong correlations, the effect size was 0.6 and 0.13 for the physical
composite summary and mental composite summary score, respectively. Most of the subscales demonstrated
significant moderate correlations with the Hospital Anxiety and Depression Scale, from −0.265 to −0.516. The discriminant
validity was confirmed with a significant difference between the dialysis and transplant group patients. A high intraclass
correlation of >0.98 was demonstrated in the test-retest.
Conclusion: The Cantonese Chinese KDQOL-36™ was reliable. Further testing will be required to determine its validity
for the physical health summary scale.
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According to the World Health Organization, the number
of patients who have End Stage Renal Disease (ESRD) and
are receiving renal replacement therapy (RRT) is increas-
ing dramatically worldwide. It is estimated that more than
1.4 million people receive RRT, and the incidence of ESRD
is growing by around 8% annually [1]. The Hong Kong
Renal Registry Report showed that in 2011, 8199 patients
received RRT, of which 3401 underwent peritoneal dialy-
sis, 945 received haemodialysis, and 3234 were living with
a functioning renal transplant [2]. The above patients were
treated by hospitals or dialysis centres operated by the
Hospital Authority of Hong Kong. Patients who were* Correspondence: susan.chow@polyu.edu.hk
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unless otherwise stated.receiving RRT solely in the private sector were not in-
cluded in the report.
The goal in providing RRT is not only to prolong life
and maintain health but also to sustain the patient’s
quality of life (QoL) [3]. Given the potentially profound
physical changes resulting from dialysis, clinicians need
to monitor patients not only for physical health but for
psychological health. In the United States, the Center for
Medicare Services now requires dialysis facilities to per-
form routine measurements of Health Related Quality of
Life, preferably using the Kidney Disease Quality of Life-
36 questionnaire (KDQOL-36™), with additional instru-
ments if appropriate [4].
The Kidney Disease Quality of Life (KDQOL™) is a self-
reported questionnaire that combines the generic SF-36
Health Survey instrument and disease-specific compo-
nents for assessing the health-related quality of life ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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KDQOL-SF™, which consists of eight subscales with 43
items on kidney disease and SF-36, was developed by the
same author. An even briefer version is becoming popular
in clinical trials because it can be completed in a short
time. This is the KDQOL-36™, an abbreviated form of the
KDQOL-SF™, which consists of the SF-12 Health Survey
instrument plus 24 items on quality of life related to kid-
ney disease [6]. The Cantonese Chinese version of the
scale was translated by Amgen, Inc. and the MAPI Insti-
tute and can be downloaded from the RAND Corpora-
tion’s website (http://www.rand.org/health/surveys_tools/
kdqol.html) for non-commercial use. The scale has been
translated into different Chinese languages, including Can-
tonese and Mandarin Chinese. Mandarin is the official
language of China, while Cantonese is a Chinese dialect.
Cantonese is spoken by the majority of people in Hong
Kong, Macau, and Guangdong province. The dialect is
also spoken by overseas Chinese communities in South-
east Asia, Australia, the United States, and Canada [7]. A
proper translation does not guarantee that the scale is reli-
able and valid in the population. The translated version of
the scale has not been evaluated by RAND, and its psy-
chometric properties have not been confirmed in a repre-
sentative sample of the population. The aim of this study
was to determine the validity and reliability of the Cantonese
Chinese KDQOL-36™ among Cantonese-speaking Hong
Kong Chinese patients undergoing dialysis. The findings
can contribute to valuable clinical applications and pro-
vide an international comparison of the quality of life
among the Cantonese-speaking population.
Methods
Structure of the KDQOL-36™
The KDQOL-36™ combines generic domains with disease-
specific domains. The disease-specific core has 24 items
comprising three scales: Symptoms and Problems (12
items), Burden of Kidney Disease (4 items), and Effects of
Kidney Disease (8 items). The items of the three subscales
are embedded in the KDQOL-SF™ and they are exactly the
same as the KDQOL-SF™. The generic core is the 12-item
Short Form Health Survey (SF-12) [8]. The results of the
SF-12 instrument are summarized into the Physical Com-
ponent Summary (PCS) score and the Mental Component
Summary (MCS) score. The raw scores are transformed
linearly to a range of 0 to 100, with higher scores indicating
better HRQOL [5]. The scale was translated by RAND Cor-
poration according to the basic guidelines and specifications
on using forward and back translation (see: http://www.
rand.org/health/surveys_tools/about_translations.html).
Sampling and setting
The study protocol was approved by the Human Sub-
jects Ethics Application Review System of the Universityand the Cluster Research Ethics Committee, Hospital
Authority, Hong Kong Special Administrative Region
with which the authors were affiliated, and performed in
accordance with the ethical standards that had been laid
down. All of the subjects gave their written consent
prior to their inclusion in the study. They were patients
attending the renal dialysis unit of a regional hospital
and its satellite dialysis centre in Hong Kong. Two
groups of subjects were recruited in this study. The first
group consisted of patients over the age of 18 who had
been undergoing dialysis treatment for at least three
months and who were able to respond to the question-
naire. The second group were patients who had under-
gone a renal transplant at least one year ago. The criteria
for exclusion were patients who had been diagnosed with
mental illness and who were not able to respond to the
questionnaire. Since the items of KDQOL-36 are embed-
ded in KDQOL-SF, the two groups of patients were re-
quired to complete KDQOL-SF and the demographic
questionnaire. We retrieved the items of KDQOL-36 from
KDQOL-SF for analysis.
With regard to sample size, a good reliability estimate
should involve at least 50 or more subjects [9]. The
minimum sample size required for testing the validity
and reliability of an instrument is 80 and 20 subjects,
respectively [10]. In our present study, we set out to
compare the QoL of dialysis patients and renal trans-
plant patients. Based on a medium effect size of 0.5 be-
tween the two groups, with an alpha of 0.05 and a
power of 0.8, the required sample for each group was
64. Based on the above information, the estimated sam-
ple size for the study would be no less than 80. A total
of 110 dialysis patients and 122 renal transplant pa-
tients were included in this study through convenience
sampling.
Validity estimate
A test of an instrument’s validity is an examination of
whether the instrument measures what it is supposed to
measure, and a variety of approaches should be used ra-
ther than a single approach [11]. In this study, the criter-
ion, convergent, and discriminant validity were evaluated.
Since the three subscales for kidney diseases are exactly
the same for the KDQOL-SF™ and KDQOL-36™, our study
mainly focused on determining the validity of the SF-12
Health Survey, which is embedded in the scale. The valid-
ity and reliability of the Chinese Hong Kong version of
SF-36 was determined in 1998 [12], and the physical and
mental health summary scales were considered valid and
reliable in a Chinese population in Hong Kong [13]. The
validity of the Chinese version of SF-12 was determined
by various authors using data collected from adolescents,
healthy adults, and participants with chronic diseases
[14-16]. Despite the previous validation, there is still a lack
Table 2 Comparisons of the KDQOL-SF™ and KDQOL-36™
PCS Mean ± SD
KDQOL-SF™ 36.27 ± 8.31
KDQOL-36™ 27.44 ± 12.53
Difference 8.82 (p < 0.001)
Correlation 0.847 (p < 0.001)
Effect size 0.70
MCS
KDQOL-SF™ 41.12 ± 11.27
KDQOL-36™ 42.92 ± 13.01
Difference −1.80 (p = 0.003)
Correlation 0.882 (p < 0.001)
Effect size 0.14
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SF-12 for chronic kidney disease patients.
Criterion validity and equivalence is considered critical
as it helps to provide evidence of the extent to which the
outcomes of a new scale correlate with the outcomes on
a criterion test [17]. Since the KDQOL-36™ data were
extracted from the KDQOL-SF™, the criterion validity
and scale equivalence of the KDQOL-36™ were exam-
ined using KDQOL-SF™ scores as the gold standard. The
effect size for the PCS and MCS between the KDQOL-
SF™ and KDQOL-36™ were used to examine whether the
two scales are equivalent. We hypothesized that there
should be strong correlations between the KDQOL-SF™
and KDQOL-36™ scores, while the effect size of the two
scales would be small. Convergent validity involves in-
vestigating the correlational evidence of a measurement
using another measure scale [11]. Previous studies showed
a positive association between health-related QoL and de-
pression among chronic disease patients, for example,
Parkinson’s disease, epilepsy, and chronic dialysis patient
groups [18-20]. The Hospital Anxiety and Depression
scale was used to identify the correlations between depres-
sion and QoL. The lower scores indicate less anxiety and
depression. We hypothesized that there would be moder-
ate, negative significant correlations between the outcomes
of the two scales. As for discriminant validity, it is an ap-
proach to assess the degree to which an instrument yields
different results when measuring two different subgroups








Gender n (%) n (%) 0.052c
Male 75 (68.2%) 68 (55.7%)
Female 35 (31.8%) 54 (44.3%)
Age (Mean ± SD) 58.21 ± 15.22 51.83 ± 10.31 *< 0.001t
Marital Status, n (%) 0.513 c
Not married 20 (17.3%) 27 (22.3%)
Married 91 (82.7%) 94 (77.7%)
Kind of dialysis
Haemodialysis 36 (32.7%)
Peritoneal dialysis 74 (67.3%)
Education *< 0.001c
Primary school or below 40 (36.4%) 12 (10.1%)
Secondary school but
not graduated
29 (26.4%) 30 (25.2%)
Secondary school 26 (23.6%) 47 (39.5%)
College or above 15 (13.6%) 30 (25.2%)
tContinuous variables were analyzed by independent-samples t test.
cCategorical variables were analyzed by Pearson Chi-square test.
*p < 0.05.group experienced less pain and discomfort, higher energy
levels, good mobility, and enjoyed better personal relation-
ships than the dialysis patients [22]. We hypothesized that
there would be a significant difference in QoL between
the dialysis and transplant group patients.
Reliability estimate
The reliability of a scale is defined as the ability of an in-
strument to produce similar results after being repeatedly
applied to the same group of subjects [23]. The Cantonese
Chinese KDQOL-36™ was administered twice to 20 dialy-
sis patients within an interval of 10 to 14 days to deter-
mine the reproducibility of the instrument. Other than
test-retest reliability, the Cronbach’s alpha coefficient was
examined on the subscales for internal consistency.
Data analysis
SPSS, version 21.0 (IBM SPSS Inc., Chicago, IL, USA),
was used to perform the data analysis. Descriptive statis-
tics were used to examine the demographic characteris-
tics of the participants. The SF-12 data were extracted
from the SF-36 data. For validity testing, criterion valid-
ity was assessed using Spearman’s rho correlation coeffi-
cient between the subscales scores of the KDQOL-SF™
and KDQOL-36™. A further examination was carried out
using the effect size to determine whether the KDQOL-36™
gave similar results from those of the KDQOL-SF™. ForTable 3 Correlations between the KDQOL-36™ and Hospital
Anxiety and Depression Scale
Subscale scores HADS (Anxiety) HADS (Depression)
Symptom/problem list r = −0.49** r = −0.372**
Effects of kidney disease r = −0.496** r = −0.24*
Burden of kidney disease r = −0.445** r = −0.396**
KDQOL-36™ (PCS score) r = −0.247* r = −0.447**
KDQOL-36™ (MCS score) r = −0.484** r = −0.5**
Spearman Rho correlation coefficient, *p < 0.05, **p < 0.001.
Table 4 Correlation coefficients matrix among five subscales scores of KDQOL-36™




KDQOL-36™ (PCS) KDQOL-36™ (MCS)
Symptom/problem list 1.00
Effects of kidney disease 0.525** 1.00
Burden of kidney disease 0.469** 0.371** 1.00
KDQOL-36™ (PCS) 0.491** 0.184 0.253* 1.00
KDQOL-36™ (MCS) 0.412** 0.405** 0.347** 0.055 1.00
Spearman Rho correlation coefficient, *p < 0.05, **p < 0.001.
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compare the QoL of dialysis patients and patients who
had undergone a renal transplant. For convergent validity,
Spearman Rho correlations were used to examine the
strength of the relationship of the KDQOL-36™ with the
Hospital Anxiety and Depression scores. The test-retest
reliability was estimated using intraclass correlation coeffi-
cients (ICC). Internal consistency reliability was evaluated
using the Cronbach’s alpha coefficient calculated separ-
ately for each subscale. Statistically significant levels were
set at a p-value of <0.05.
Results
Sample characteristics
The mean age of the dialysis patients was 58.21 ±
15.22 years, while that of the transplant patients was
51.83 ± 10.31 years. The majority of the subjects were
married and there were more peritoneal dialysis patients
in the dialysis group. With regard to education levels,
more than one third of the dialysis patients had a primary
school education or less, while 64.7% of the transplant pa-
tients had completed secondary school education or
above. There were significant differences between the two
groups in gender, age and level of education. Please see
Table 1 for details.
Validity tests
With regard to criterion validity, there were very strong
positive correlations between the KDQOL-36™ and
KDQOL-SF™ for the PCS and MCS scores. The correla-
tions between the corresponding summary scores were
greater than 0.85 with p < 0.001. With regard to the ef-
fect size, it was calculated by dividing this difference by
the standard deviation (SD) of the SF-36 summary scoreTable 5 Comparisons of the QOL of dialysis and transplant pa
Kidney disease-targeted scales Dialysis group (n = 110)
Symptom/problem list 68.75 (58.33 – 82.81)
Effects of kidney disease 56.25 (42.19 – 68.75)
Burden of kidney disease 25 (7.81 – 43.75)
KDQOL-36™ (PCS) 36.02 (29.94 – 43.36)
KDQOL-36™ (MCS) 39.13 (32.49 – 49.16)
Mann–Whitney U test **p < 0.05.[24]. The mean and standard deviation of the PCS for
the KDQOL-SF™ and KDQOL-36™ was 36.27 ± 8.31 and
27.44 ± 12.53, respectively, with an effect size of 0.70.
For the MCS, the mean and standard deviation for the
KDQOL-SF and KDQOL-36 was 41.12 ± 11.27 and
42.92 ± 13.01 and, respectively, with an effect size of
0.14. There were significant differences in PCS and MCS
scores among the two scales. Table 2 shows the details.
The convergent validity was established by exploring the
correlations of the subscales with the domains of the Hos-
pital and Anxiety Scale. There were negative low to mod-
erate correlations between anxiety and the PCS and MCS,
with r = −0.328 (p < 0.001) and r = −0.459 (p < 0.001), re-
spectively. The low to moderately negative correlations
were found between depression and the PCS and MCS,
with r = −0.265 (p < 0.05) and r = −0.516 (p < 0.001), re-
spectively. The correlations between anxiety, depression,
and the kidney disease targeted scales were moderate. The
details are given in Table 3. The correlation matrix among
the five subscale scores of KDQOL-36™ was shown in
Table 4. There were moderate correlations between most
of the subscales, except the correlations between PCS and
Effects of Kidney Disease, and PCS and MCS scores.
The independent t-test was used to compare the QoL
of the dialysis patients and patients who had undergone
a renal transplant. There were significant differences be-
tween the two groups in the three subscales for kidney
disease, and the PCS and MCS of the KDQOL-36. Please
refer to Table 5 for details.
Reliability estimate
With regard to internal consistency, the coefficients of
the three subscales related to kidney disease ranged from
0.65 to 0.83, which was evidence of adequate to goodtients
Transplant group (n = 122) p-value
83.33 (75 – 91.67) **< 0.001
81.25 (65.63 – 90.63) **< 0.001
62.5 (43.75 – 81.25) **< 0.001
47.25 (39.45 – 52.57) **< 0.001
49.18 (43.93 – 55.67) **< 0.001
Table 6 Internal consistency, test-retest reliability of the PCS, MCS, and kidney disease targeted scales
Items Test-retest reliability ICC
(Confident interval)
Kappa Weighted kappa Cronbach’s alpha
(Dialysis group)
Symptom/problem 0.997 (0.991-0.999) 0.826-1 0.851-1 0.833
Effects of kidney disease 0.983 (0.951-0.994) 0.75-1 0.828-1 0.794
Burden of kidney disease 1 1-1 1-1 0.651
PCS 0.993 (0.981-0.998) 0.688-1 0.737-1 0.322
MCS 0.996 (0.989-0.999) 0.537
Table 7 Comparisons of SF-36 and Chinese (HK) specific
SF-12
PCS Mean ± SD
SF-36 27.44 ± 13.35





SF-36 42.92 ± 13.86




Spearman’s rho correlation, **p < 0.01.
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MCS was 0.32 and 0.53, respectively. Regarding test-
retest reliability, the ICCs were above 0.98 for the five
subscales. Other than ICCs, the Kappa and Weighted
Kappa index were examined. The Kappa index of the
five subscales ranged from 0.68-1, whilst the Weighted
Kappa index ranged from 0.73-1. The results of the reli-
ability tests are given in Table 6.
Discussion
In summary, the majority of previous studies assessing the
validity and reliability of the KDQOL-36™ have been con-
ducted in the West [6,25]. This is the first time that the
Cantonese Chinese KDQOL-36™ has been validated on dia-
lysis patients in Hong Kong. Our results suggest that the
scale is reliable and has an acceptable level of validity for
understanding the health-related QoL of dialysis patients.
Criterion validity of the Cantonese Chinese KDQOL-36
There were high correlations, at r >0.84, between the
physical and mental summary scores of SF-36 and SF-
12. SF-12 demonstrated evidence of criterion validity, as
the two scales were very similar. Despite the high corre-
lations on the PCS and MCS, our study was unable to
draw any conclusions on the equivalence of SF-36 and
SF-12 due to the medium effect size of the PCS from the
two scales. According to Lam [26], the generally accepted
minimal clinically important difference (MCID) standard
is 0.5. For those scores with a difference in effect, <0.5 was
considered as having measurement equivalence [27]. The
moderate effect size was related to the number of items
selected for PCS in SF-12 might indicate the loss of crucial
information in the short version. In 2005, a Chinese Hong
Kong (HK) specific SF-12 was developed where six of the
items that were selected were different from those of the
standard SF-12 [16]. The scale had a different scoring al-
gorithm and was found to be more sensitive to the Hong
Kong Chinese population.
To further investigate the issue of scale equivalence,
comparisons were made using the Chinese (HK) specific
SF-12 data extracted from the SF-36 data. The results
also demonstrated high correlations between SF-36 and
the Chinese (HK) specific SF-12 on the PCS and MCSscore. Most importantly, the effect size for the PCS was
reduced to 0.32, which is within the generally accepted
MCID, while the effect size for the MCS was 0.04.
Table 7 gives details of the comparisons. The results cor-
roborated Lam’s study that the effect size decreased if
the HK specific version was used instead of the standard
version for heart disease patients. The difference in ef-
fect size could be due to the selected items in the Stand-
ard SF-12 versions being not sensitive enough to
measure the overall physical health of dialysis patients.
For instance, the dialysis patients were encouraged to
engage in moderate activities to maintain the body’s
functions. Instead of asking whether their health re-
stricted the patients to performing ‘moderate activities’,
the HK specific version was changed to ‘vigorous activ-
ities’. Because ’to climb several flights of stairs’ might
not be applicable to most Hong Kong people, as escala-
tors are available in most apartment buildings, ‘to walk
several blocks’ was therefore included in the specific
scale. Instead of asking ‘How much does pain interfere
with your normal work?’, the selected item was changed
to ‘How much pain have you had during the past 4 weeks?’
The revised item selection was able to measure an individ-
ual’s physical abilities to perform certain activities in daily
life. Moreover, it is easily comprehensible and relevant to
Chow and Tam BMC Nephrology 2014, 15:199 Page 6 of 7
http://www.biomedcentral.com/1471-2369/15/199the living circumstances in Hong Kong. The items for the
PCS in the standard SF-12 may not be an equivalent sub-
stitute for the SF-36 for Chinese dialysis patients. The
items could be revised using the HK specific version to en-
sure its equivalence.
Our results supported the hypotheses on convergent
and discriminant validity. A correlation coefficient of
above 0.4 for convergent validity is considered satisfactory
[28]. There were significant negative correlations between
the disease-specific domain scores and the depression
score, with the MCS having the highest correlation with
depression, at r = −0.516. With regard to symptoms and
problems, the effects of kidney disease and the burden of
kidney disease, the correlations were moderate. The na-
ture and progression of end stage renal disease causes pa-
tients to get used to the idea that they will need lifelong
treatment and to accept the disruption in their daily life
activities [29]. As a result, the patients were less depressed
compared with the newly diagnosed patients, even though
they were bothered by the symptoms and impacts of kid-
ney disease in their daily life. A relatively low correlation
was found between the PCS and depression. A possible
explanation for this is that the items selected in the Stand-
ard SF-12 are not sensitive enough to capture the situation
for dialysis patients. On the other hand, the evidence
shows that anxiety is common in patients on maintenance
dialysis and that this aspect is understudied [30]. In our
study, anxiety levels were less prominent with regard to
the question of whether kidney disease is a burden to pa-
tients and their families due to the prolonged trajectory of
the illness. For discriminant validity, the scale is able to
discriminate between the QoL of dialysis and transplant
patients, producing significantly different results. The re-
sults corroborated those of previous studies confirming
that transplant RRT provides a better QOL compared with
other replacement methods [31].
The KDQOL-36™ is considered reliable and to have
good reproducibility, as indicated by the high ICC value
of >0.98 in all of the subscales. For test-retest reliability,
an ICC of 0.70-0.86 demonstrated the stability of the
scale over time [32]. The Kappa Index of 0.68-1 and
Weighted Kappa of 0.73-1 indicated a substantial to per-
fect agreement across various items in test and retest re-
liability [33]. The Cronbach’s alpha values suggested that
the scale is internally reliable. The internal reliability of
all of the subscales exceeded 0.65, with the exception of
the PCS and MCS. As mentioned, the item selection for
the PCS may need to be revised using the Hong Kong
specific version to replace the standard version. The rela-
tively low Cronbach’s alpha for the MCS could have been
affected by the fewer items in the scale. Any instrument
with more than 14 items may have a higher Cronbach’s
alpha value even if the items reflect different underlying
constructs [34].Conclusions
This study showed that the Cantonese Chinese KDQOL-
36 has relatively good reliability and modest validity. It is
less sensitive at measuring the PCS scores for evaluating
general physical health. It is recommended that the HK
specific version be used to replace the Standard SF-12
for items contributing to the PCS. Testing of the reliability
and validity of the scale should be an ongoing process. A
larger sample size should be used, the items for the PCS
should be replaced, and a standalone KDQOL-36 should be
used to confirm the psychometric performance of the scale.
All of the above recommendations should be carefully con-
sidered before it can be stated that the Cantonese Chinese
KDQOL-36 is a responsive instrument for monitoring the
QoL of chronic kidney disease patients in Hong Kong.
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